Recent investigations reveal major price fixing in the generic drug sector, drastically increasing costs to consumers looking to save money. This past January, Jeffrey Glazer, the CEO of Heritage Pharmaceuticals, a subsidiary of Indian drug company Emcure Pharmaceuticals, pleaded guilty to violating US antitrust law by conspiring with manufacturers to fix the prices of generic […]
A new study provides one more reason to think twice about these powerful drugs, especially if you are pregnant. After extensive reports showing the negative effects of antidepressants, this new study, which looked at nearly 150,000 babies, has found a link between antidepressants taken during pregnancy and autism in young children. Children of women who […]
No, this isn’t about repealing or replacing Obamacare. It’s about empowering you to make your own healthcare choices. Action Alert! In February we told you about the Health Savings Act of 2017. Sponsored by Sen. Orrin Hatch (R-UT) and Rep. Erik Paulsen (R-MN), SB 403/HR 1175 allows Health Savings Account (HSA) funds to go toward […]
Lawmakers are on a course to put the FDA even deeper into the pocket of the pharmaceutical industry. Action Alert! House and Senate leaders are looking to fast-track legislation that will reauthorize the Prescription Drug User Fee Act (PDUFA), the law that allows the US Food and Drug Administration to collect fees from pharmaceutical companies […]
Rep. Jason Chaffetz (R-UT), a noted champion of natural supplements, has announced he will not seek re-election in 2018. The announcement came last week. He may even retire before his term ends. As one of natural health’s foremost advocates in Congress, we are sad to see him go. Rep. Chaffetz was a staunch supporter of […]
The FDA is likely to move against numerous natural, compounded medicines. Action Alert! The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on what supplements and drugs can be individually formulated for patients—many of whom have very specific needs that can only be met through these alternative formulations. The next meeting of the PCAC has […]
While the national movement that swept Donald Trump into office leaned heavily on a “Drain the Swamp” slogan, FDA officials are filling the swamp with more murky water and many of them are leaving the agency en masse to work at a Big Pharma consulting/lobbying firm. Greenleaf Health, which may not have been on your […]
After selling out to Big Pharma, 23andMe went from being a pariah with the FDA to being a darling. Recently, the FDA approved 23andMe’s direct-to-consumer genetic tests for ten conditions, including Parkinson’s disease, Alzheimer’s, and celiac disease. Consumers send 23andMe a saliva sample, and the company sends back genetic data analyzing the disease risk of […]
Get a second opinion, and you’ll get confused. That could be the new motto for a healthcare industry characterized by dueling diagnoses. According to a new study by the Mayo Clinic, nine out of ten people who seek a second opinion after receiving an initial diagnosis from a doctor get either a somewhat different or […]
Or just legalize an alternative? Following a politically disastrous failure to repeal and replace Obamacare earlier this year, reports suggest that House Republicans are “close” to a plan that might pass. We’ll report on this as soon as details become available. One thing, however, remains abundantly clear: consumer control must be central to any healthcare […]